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Abstract
Background: The INK4/ARF locus encodes three tumor suppressor genes (p15
Ink4b, Arf and p16
Ink4a) and is frequently
inactivated in a large number of human cancers. Mechanisms regulating INK4/ARF expression are not fully characterized.
Principal Findings: Here we show that in young proliferating embryonic fibroblasts (MEFs) the Polycomb Repressive
Complex 2 (PRC2) member EZH2 together with PRC1 members BMI1 and M33 are strongly expressed and localized at the
INK4/ARF regulatory domain (RD) identified as a DNA replication origin. When cells enter senescence the binding to RD of
both PRC1 and PRC2 complexes is lost leading to a decreased level of histone H3K27 trimethylation (H3K27me3). This loss is
accompanied with an increased expression of the histone demethylase Jmjd3 and with the recruitment of the MLL1 protein,
and correlates with the expression of the Ink4a/Arf genes. Moreover, we show that the Polycomb protein BMI1 interacts
with CDC6, an essential regulator of DNA replication in eukaryotic cells. Finally, we demonstrate that Polycomb proteins and
associated epigenetic marks are crucial for the control of the replication timing of the INK4a/ARF locus during senescence.
Conclusions: We identified the replication licencing factor CDC6 as a new partner of the Polycomb group member BMI1.
Our results suggest that in young cells Polycomb proteins are recruited to the INK4/ARF locus through CDC6 and the
resulting silent locus is replicated during late S-phase. Upon senescence, Jmjd3 is overexpressed and the MLL1 protein is
recruited to the locus provoking the dissociation of Polycomb from the INK4/ARF locus, its transcriptional activation and its
replication during early S-phase. Together, these results provide a unified model that integrates replication, transcription
and epigenetics at the INK4/ARF locus.
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Introduction
Cellular senescence is a fundamental cellular program that is
activated after a finite number of cell divisions and operates to
avoid further cell proliferation. In addition cellular senescence
constitutes a tumor suppressor mechanism [1,2]. The tumor
suppressor pathways, ARF/MDM2/p53 and p16
INK4a/Rb, have
been shown to play critical roles in the induction of cellular
senescence [3]. Studies on Polycomb group genes (Pc-G) have
demonstrated that beside their function in controlling the
expression of Hox genes, Pc-G play a central role in cell
proliferation through the repression of the INK4/ARF locus
[4,5,6]. This locus encodes both p16
INK4a, which prevents
inactivation of the tumor suppressor RB, and p19
ARF, which
stabilizes the tumor suppressor p53 [7,8]. Evidence supporting the
direct control of the cell cycle by Pc-G proteins in vertebrates
came from studies on mouse Bmi1 mutants. Bmi1 was first
identified as a proto-oncogene that cooperates with c-Myc to
promote the generation of mouse B- and T-lymphomas [9]. Mice
lacking Bmi1 exhibit strong proliferative defects during lymphocyte
development. In the absence of Bmi1, M33, or Phc2, primary
embryonic fibroblasts (MEFs) are unable to progress into S phase,
undergo premature senescence after only a few passages in culture
and show an increased accumulation of the tumor suppressors
p16
INK4a, p19
ARF and p15
INK4b [4,10]. Generation of Bmi1/
Ink4a/Arf compound mutant mice have provided genetic evidence
that at least part of these defects are due to activation of the
INK4a/ARF locus [11].
Pc-G and Trx-G proteins function in distinct multiprotein
complexes which control transcription by altering the structure of
chromatin, organizing it into either a ‘‘closed’’ or an ‘‘open’’
conformation. The Trx-G protein MLL1 mediates lysine-directed
histone methylation [12,13]. Methylation on lysine-4 of histone
H3 (H3K4me2 and H3K4me3) is associated with a permissive and
transcriptionally active state of the chromatin [14]. Pc-G proteins
are transcriptional repressors that functionally can be separated
into at least two different complexes: the initiation complex,
Polycomb complex 2 (PRC2), which in humans consists of EZH2,
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core proteins RNF2, HPC, and BMI1. Both PRC1 and PRC2
complex members have been linked to cell cycle control. EZH2 is
the active component of PRC2 through its SET domain histone
methyltransferase activity specific for Lys 27 (K27) of histone H3
and K26 of histone H1 [15,16]. It has been demonstrated that
PRC2 is required for PRC1 binding to chromatin [17],
presumably achieved through binding of HPC protein to
H3K27me3 [15]. It has recently been shown that Polycomb
proteins are bound to the INK4a/ARF locus and dissociated during
senescence [18]. We have now extended this study and
demonstrate that both Polycomb and the trithorax (Trx-G)
member MLL1 are localized at this locus and importantly
associated to the Regulatory Domain (RD) of the INK4/ARF
locus identified as a DNA replication origin and as a global
transcriptional regulator of the entire locus [19,20]. Also, we
demonstrate that BMI1 interacts with the licencing factor CDC6.
Finally, we show that the late timing of replication of the INK4a/
ARF locus in young proliferating MEFs shifts to an early
replication timing in senescent and notably in PRC2 mutant
MEFs. Together our results demonstrate that MLL1 and
Polycomb group genes directly control the INK4a/ARF locus
through epigenetic chromatin modifications and that the loss of
repressive epigenetic marks both in senescent and Polycomb
mutant cells leads to a shift of the replication timing of the INK4a/
ARF locus.
Materials and Methods
Mouse embryonic fibroblasts (MEFs)
Day-12p.c. wild type, M33 mutant and Bmi1 mutant embryos
were mechanically dissociated into single cells and cultured in
DMEM with 10% FCS and penicillin and streptomycin (Invitro-
gen, Breda, The Netherlands). MEFs were passaged every two to
three days and viable cells were counted by Trypan Blue
(Invitrogen) exclusion. Senescent cells were detected using the
beta-Galactosidase Staining Kit (BioVision) following the manu-
facturer’s recommendations.
Quantification of mRNA levels by Q-PCR
For reverse transcriptase Q-PCR (Q-RT-PCR) analysis, total
RNA was extracted from MEFs with the RNeasy Mini Kit
(QIAGEN) according to the manufacturer’s protocol. cDNA was
synthesized from 1 mg of total RNA using the QuantiTect Reverse
Transcription Kit (QIAGEN). Q-PCR amplification of either
mouse Ink4a transcripts or Arf was performed with the SYBR
Green PCR Master Mix Kit (Applied Biosystems) in a 7500 Real-
Time PCR System From Applied Biosystems. Primers used are
given in Table 1. Q-RT-PCR analysis of Gapdh mRNA expression
was performed as a positive control and for normalization.
Retroviral transduction of embryonic fibroblasts (MEFs)
Ecotropic virus producer cells (Phoenix) were transfected with
pMSCV-Myc-cdc6 or the empty vector (mock) using Lipofectami-
ne
TM 2000 Reagent (Invitrogen). Retroviral supernatant was
collected after 24 h. For transduction wild type and Bmi
2/2 MEFs
were plated in 6-well plates. Cells were incubated with the viral
supernatant and Polybrene (4 mg/ml) for 30 min before centrifu-
gation(2000 rpm,32uC, 60 min). After12 h incubation (10% CO2,
37uC) cells were washed and incubated with fresh medium.
Immunocytochemistry
MEFs (wild type and BMI
2/2) were transduced with pMSCV-
Myc-cdc6 or the empty vector (mock) at passage P3. 72 h after
transduction, cells were plated on glass coverslips, fixed in 4%
paraformaldehyde and permeabilized with cold PBS containing
0.2% Triton X-100. After blocking, the cells were incubated with
primary antibodies (mouse anti-Cdc6 (sc-9964; Santa Cruz
Biotechnology), rabbit anti-p16
INK4a (sc-1207; Santa Cruz Bio-
technology), washed with secondary antibodies, stained with
DAPI, and mounted before viewing.
Chromatin immunoprecipitation assays
ChIP were performed and analyzed essentially as described
[16]. The antibodies used were rabbit anti-H3acetyl (06-599,
Upstate Biotechnology), rabbit anti-H3K27me3 (07-449; Upstate
Biotechnology), rabbit anti-M33 (kind gift of Dr. Higashinaka-
gawa, T) [21], rabbit anti-H3K4Me3 (05-745; Upstate Biotech-
nology), rabbit anti-EZH2 (07-689; Upstate Biotechnology), goat
anti-BMI1 (sc-8906; Santa Cruz Biotechnology), anti-MLL (05-
765; Upstate Biotechnology). For normal ChIP, the immunopre-
cipitated DNA was quantified by real-time Q-PCR (Applied
Biosystems) and normalized with the 1/5 input. The sequences of
the PCR primers are listed in Table 1.
Coimmunoprecipitations
NIH3T3 cells were transiently transfected with pCG-HAcdc6
using Lipofectamine
TM 2000 Reagent (Invitrogen) following the
manufacturer’s instructions. 72 h after transfection CoIP were
performed using Nuclear Complex Co-IP Kit (active motif) with
mouse anti-HA (2367; Cell Signaling). Thymocytes were isolated
from 5 to 7 weeks old mice and protein extraction and CoIP were
performed using Nuclear Complex Co-IP Kit (active motif) with
mouse anti-BMI1 (05-637; Upstate Biotechnology). Western
blotting procedure and reagents for western blot analysis were
previously described [4]. Antibodies used were mouse anti-CDC6
(sc-9964; Santa Cruz Biotechnology), goat anti-BMI1 (sc-8906;
Santa Cruz Biotechnology).
Table 1. Sequences of Primers used for ChIP and gene
expression analysis
Primer Sequence 59-39
RD
INK4a/ARF fwd TTCCTATTTCGCTGTAGCAAC
RD
INK4a/ARF rev AACTAACCAGGCCTCCTCCCA
Exon 1b fwd AGGTGCCTCAACGCCGAAG
Exon 1b rev CTGGTCCAGGATTCCGGTGCGG
Exon 2 fwd ATGGGCAACGTTCACGTAGCAGC
Exon 2 rev AGCGGTACACAAAGACCACCCA
p19
ARF fwd TCGCAGGTTCTTGGTCACTGT
p19
ARF rev TGCTACGTGA ACGTTGCCCA
p16
INK4a fwd GTGTGCATGACGTGCGGG
p16
INK4a rev GCAGTTCGAATCTGCACCGTAG
Ezh2 fwd AGGATACAGCCTGTGCACATCATGA
Ezh2 rev GATCCAGAACTTCATCCCCCATAT
Bmi-1 fwd CCAGCAAGTATTGTCCTATTTGTGA
Bmi-1 rev TTGAAGAGTTTTATCTGACCCTTATGTT
UTX fwd GCAAGTGCAGATACATGGTGTTC
UTX rev GCCTAGATCCATCCAGGCTGC
JMJD3 fwd GGAAGCCACAGCTACAGGAGC
JMJD3 rev CCCAATAGTGCTCATGTACCGC
doi:10.1371/journal.pone.0005622.t001
PcG Ink4a Replication Timing
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BrdU labeling, fixation in cold 70% ethanol, cell cycle
fractionation by flow cytometry and isolation of BrdU-labeled
DNA by immunoprecipitation were carried out as previously
described [22].
Results and Discussion
Polycomb expression and cellular senescence in mouse
embryonic fibroblasts
To study cellular senescence we have used serial passaging of
mouse embryonic fibroblasts (MEFs) cultured from 12-day-old
C57BL/6 embryos. As already described, MEFs were able to
undergo a limited number of population doublings (P12) before
they senesced. Senescence was assessed by monitoring the
endogenous B-galactosidase (B-gal) activity at pH 6 (Fig. 1B). At
this stage (P10), cells overexpress both p16
Ink4a and p19
Arf.A s
expected knock out cells derived from PRC1 members Bmi1 and
M33 overexpress both p16
Ink4a and p19
Arf as soon as passage P3
[4] (Fig. 1A). Since EZH2 is required for Polycomb silencing we
measured differences in expression levels of Ezh2 in young and
senescent MEFs by Q-RT-PCR (Fig. 1C). Protein levels of EZH2
(not shown) in MEFs correlated with RNA levels; Ezh2 is more
abundant in early passage (P3) than in senescent MEFs (P10)
(Fig. 1C). In PRC1 mutant cells (M33, Bmi1) the expression level
of Ezh2 is strongly diminished. Interestingly, expression level of
the PRC1 member Bmi1 is not modified in senescent cells as
compared to young proliferating cells (Fig. 1C) [18].
Polycomb proteins are localized at the RD
INK4a/ARF
The RD
INK4a/ARFhas been identified as a putative DNA
replication origin that assembles a multiprotein complex contain-
ing CDC6 and that coincides with a conserved non coding DNA
element identified as a transcriptional regulatory element [20].
Whether PRC1 and PRC2 members bind directly to RD
INK4/ARF
had not been tested yet. In order to assess this question, we
performed ChIP assays to examine whether EZH2 directly binds
this transcriptional regulatory element. Oligonucleotide primers
were designed in order to examine in young proliferating MEFs
the distribution of EZH2 at the RD element and along the INK4a/
ARF locus. We found that EZH2 is bound to the first exon of ARF,
exon 1b, and with a maximum peak to the shared exon of INK4a
and Arf, exon 2, in early-passage MEFs (Fig. 1D). Interestingly, we
found that both EZH2 and PRC1 members BMI1 and M33 are
also localized at the RD origin of replication in young proliferating
MEFs. In contrast, in senescent cells most of the bound EZH2 and
M33 protein was lost at all the examined sites along the INK4a/
ARF locus (Fig. 1D and E). A significant part of BMI1 is still
retained at both exon 1b (p19
ARF) and at the shared exon 2 upon
senescence (Fig. 1F) however interestingly, BMI1 completely
disappeared from RD (Fig. 1F). Since EZH2 and M33 are lost
from the entire locus in senescent cells, these results suggest that
BMI1 may bind to some parts of the locus (exon 1b and exon 2) in
a manner that is independent of EZH2 and M33, but its binding
to RD appears dependent on those two proteins. It has recently
been shown that the BMI1 protein was dissociated from the locus
at senescence [18]. While we do not explain this difference, the
detected BMI1 protein bound at the locus correlates well with the
fact that the expression level of Bmi1 is not modified in senescent
cells. However, it was demonstrated using genome wide analysis
that Polycomb domains can be segregated in two classes: the first
occupied by both PRC2 and PRC1 (PRC1-positive) and the
second specifically bound by PRC2 (PRC2-only) [23,24].
Several experiments indicate that H3K27 methylation by E(z)
has a critical function in the establishment of transcriptional
repression of PRC2 target genes. It has been demonstrated that
the PRC2 complex containing E(z)/EZH2 is an active enzyme
capable of methylating the histone H3 tail at lysine-9 (K9) and
more importantly at K27 [15,25]. In E(z) Drosophila mutants the
loss of functional E(z) induces a loss of Pc-G protein binding to
polytene chromosomes [26]. Methylation of histone H3K27 by
E(z) protein is strictly required for maintenance of HOX gene
silencing in Drosophila [27]. Drosophila Polycomb (Pc or M33 in
mouse), a core subunit of PRC1, selectively binds to histone H3
tail peptide trimethylated at K27, suggesting that H3K27me3 may
contribute to targeting of PRC1 to HOX genes [28,29]. We
therefore examined the status of methylation of histone H3 at the
RD element and at the INK4a/ARF locus in young, senescent and
Polycomb mutant cells. As shown in figure 2, H3K27me3 marks
are lost from the RD element in senescent cells and from the
shared exon 2 in senescent, Bmi1
2/2 and M33 mutant MEFs. The
loss of the H3K27 repressive mark correlates with the higher
transcription of Arf and Ink4a in senescent and Polycomb mutant
cells (Fig. 1A). Histone acetylation is generally viewed as a central
switch that allows exchange between permissive and repressive
chromatin domains in terms of transcriptional competence. It was
shown that the levels of p19
Arf are strongly upregulated in murine
cells treated with histone deacetylase inhibitors (HDACis) [30].
Yet, examination of acetylation of histone H3(K9,K14) in actively
cycling and senescent cells shows low level of H3 acetylation at the
INK4a/ARF locus (Fig. 2). In contrast, we observe a strong
enrichment of acetylated H3 at the Arf promoter in M33 and Bmi1
knockout MEFs (Fig. 2) similar to the effects observed after
treatment with HDACis [30].
MLL1 is recruited to the INK4a/ARF locus during
senescence
In Drosophila and in mouse the activity of Trx-G/MLL
complexes is required to prevent Pc-G-mediated silencing of
transcribed Hox genes [31,32,33,34]. MLL1 protein complexes
catalyze the trimethylation of H3K4, which is generally associated
with active transcription [35]. Accordingly, H3K4me3-modified
nucleosomes are specifically enriched at the promoters of active
genes [36]. We therefore monitored the binding of the MLL1
protein and the associated H3K4me3 positive transcriptional mark
at the RD element and at the INK4a/ARF locus in MEFs during
senescence and in Polycomb mutant cells. MLL1 was bound to the
RD element and to both exon 1b and p16
INK4a/p19
ARF shared
exon 2 in young cells (Fig. 3A). However, in both senescent and
Polycomb mutant cells we observe a strong enrichment of MLL1
binding at the locus demonstrating that MLL1 participates to the
transcription of Arf and Ink4a. Surprisingly, we did not observe a
similar increase of the H3K4 methyl mark during senescence and
in mutant cells (Fig. 3A). This positive mark is equally present in
young, senescent or Polycomb mutant cells at the INK4a/ARF
locus. Patterns of methylation at lysine 4 and 27 of histone H3
have been associated with gene activation and repression that are
developmentally regulated and are thought to elicit the coordina-
tion of lineage specific gene expression programs [37]. Interest-
ingly, in ES cells, the Polycomb Hox target gene promoters often
display both H3K4me3 and H3K27me3 marks, and such regions,
containing both repressing and activating chromatin modifica-
tions, were referred to as ‘‘bivalent domains’’ [38]. In stem cells,
these bivalent domains may keep selected genes ‘‘poised’’ for
activation. H3K27me3 is a rather stable modification, which could
be progressively lost in the absence of PRC2, along with cell
divisions [39]. However, studies in ES cells indicated that changes
PcG Ink4a Replication Timing
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5622Figure 1. Analysis of Polycomb EZH2, M33 and BMI1 binding at the INK4a/ARF region. A) qPCR analysis of p16
INK4a and p19
ARF in young (P3),
senescent (P10) and in Bmi1 and M33 mutant MEFs. B) B-galactosidase staining to detect senescent cells at passage 3 (P3) and passage 10 (P10). C) qPCR
analysis of the mRNA levels of Polycomb EZH2 and Bmi1 in the indicated cells. D–F) Schematic diagram of the INK4a/ARF locus: amplified regions that
were tested in ChIP experiments are indicated by red bars (sequences are given in Table 1). Wild type P3 (young), P10–12 (senescent), M332/2 (P4) and
Bmi2/2 (P4) MEFs were subjected to ChIP assays using anti EZH2, BMI1 and M33 antibodies. DNA enrichment was calculated as described in Materials
and Methods. Bars represent the mean+/2s.d. of quantifications from two to four separate immunoprecipitations analyzed in triplicate.
doi:10.1371/journal.pone.0005622.g001
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occur promptly, and involving an appropriate demethylase
activity. We therefore monitored the expression of both Jmjd3
and Utx H3K27 histone demethylases. As shown in figure 3B
expression of Utx is not modified in young, senescent or M33
mutant cells. However, transcription of Jmjd3 is significantly
induced in senescent MEFs. These results strongly suggest that the
upregulation of Jmjd3 (Fig. 3B) and the downregulation of Ezh2
(Fig. 1C) are critical determinants of the transcriptional activation
of the INK4/ARF locus during senescence. It has been shown that
UTX can interact with components of the MLL2 complex
[40,41]. This physical association between enzymes removing the
H3K27me3 repressive mark, on the one hand, with protein
complexes promoting the deposition of the active H3K4me3
mark, on the other hand, suggests that both activities are required
for a rapid and stringent response of target genes. MLL1 is cleaved
by Taspase1, generating an N-terminal and a C-terminal
fragment, which can heterodimerize in vitro [42,43]. In Drosophila
it was demonstrated that TRX-N is present at thousand genomic
sites, where no Pc-G binding can be observed. However, it was
shown that TRX-C is strongly bound at Pc-G binding sites [44].
These results suggest the C-terminal part of TRX is specifically
linked to Pc-G function. It was suggested that Pc-G proteins might
repress transcription by anchoring the C-terminal portion of TRX
at Polycomb response elements (PREs/TREs) or that constitutive
TRX-C binding at PREs/TREs might allow Pc-G target genes to
switch their state upon transcriptional induction [44].
Physical and Functional Association of BMI1 and CDC6 in
replication control
The identification of a DNA replication origin (RD) adjacent to
INK4b [19,20] and its high degree of sequence conservation led to
ask whether this domain might contribute to the regulation of
transcription. Interestingly, overexpressing and loading CDC6 to
the RD element, results in the transcriptional repression of all
three genes in the INK4b–ARF–INK4a locus [45] leading to
increased foci formation and enhanced transformation by
oncogenic RAS. Importantly, silencing is accompanied by the
recruitment of histone deacetylases and increased methylation of
histone H3 on lysine 9 (H3K9), which are hallmarks of
heterochromatin. We have demonstrated that both components
of the PRC2 and PRC1 complex are localized at the RD element.
This prompted us to search for possible physical interactions
between the replication complex containing CDC6 and the
components of Polycomb complexes. Co-Immunoprecipitation
experiments using an antibody against BMI1 demonstrated that
CDC6 is associated in a complex with BMI1 (Fig. 4B). Moreover
using thymocytes we show that the CDC6-BMI1 interaction
Figure 2. Loss of EZH2 binding and H3K27me3 methylation at the INK4a/ARF locus during senescence. P3 proliferating and P10–12
senescent MEFs were subjected to ChIP assays using the indicated antibodies.
doi:10.1371/journal.pone.0005622.g002
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the CDC6-BMI1 interaction is not due to the forced expression of
CDC6 in transfected MEFs. In order to test if BMI1 is required for
Ink4a/Arf repression mediated by CDC6, we transfected CDC6
in Bmi1 knock out and wild type MEFs. As already described [20],
the forced expression of Cdc6 in wild type MEFs decreased the
protein levels of ARF and INK4a (Fig. 4A,D). However,
overexpression of Cdc6 in mutant Bmi1 cells failed to mediate
Figure 3. Recruitment of MLL1 at the INK4a/ARF locus during senescence. A) ChIP analysis of the RD element, p19
ARF exon 1b and p16/19
shared exon 2 using MLL-c antibody and H3K4me3 antibody. B) qPCR analysis of the mRNA levels of UTX and JMJD3 histone demethylase in the
indicated cells.
doi:10.1371/journal.pone.0005622.g003
PcG Ink4a Replication Timing
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induced repression of the INK4a/ARF locus is dependent on
Polycomb function.
Next we asked whether the localization of Polycomb proteins at
an origin of replication together with the replication machinery [19]
could affect replication of the locus. To investigate whether the
Figure 4. BMI1 interacts with CDC6 and is required for CDC6 repressing function. A) Western Blot analysis of Myc-CDC6 Wild type and
Bmi1 mutant transduced cells. The antibodies used are indicated. GAPDH antibody is used as a loading control. Ab) quantitative PCR experiment
showing p16
INK4a and p19
ARF expression in Myc-CDC6 transduced Bmi1 mutant cells. B) CDC6 interacts specifically with BMI1: HA
immunoprecipitated proteins extracted from HA-CDC6 transfected cells were separated by SDS-PAGE and immunoblotted with a BMI1 antibody.
C) anti-Bmi1 immunoprecipitated proteins extracted from wild type thymocytes and immunoblotted with a CDC6 antibody. D) BMI1 is required for
INK4a CDC6 mediated repression. Wild type MEFs transfected with Myc-CDC6 were immunostained with a specific antibody against p16
INK4a (red)
and CDC6 (green) middle panel. Untransfected cells are shown on the upper panel. Bmi1 mutant cells transfected with Myc-CDC6 (green) express
high level of p16 (red) (Bottom panel).
doi:10.1371/journal.pone.0005622.g004
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replication timing of the INK4a/ARF locus we examined young
proliferating (P3), pre-senescent (P7) and Polycomb M33 mutant
(P3) MEFs. The replication timing was assessed using a PCR based
approach [22,46]. Non-synchronized cells were pulse labeled with
59Bromodeoxyuridine (BrdU), stained with propidium iodide (PI)
and sorted according to DNA content by flow cytometry (Fig. 5).
Newly synthesized DNA was isolated by immuno-precipitation with
anti-BrdU antibody. As shown in figure 5 the exon 1b (p19
ARF)i s
late replicating in young cells which do not express the Arf or Ink4a
genes;whereasthisregionbecomesearlyreplicatinginpre-senescent
and in M33 mutant cells when the Arf or Ink4a genes are expressed.
In higher eukaryotes, it has been observed that the time of
replication and transcriptional activity are often correlated; genes
which are late replicating are not expressed while transcriptionally
active regions are early replicating [47]. In addition, when the
transcriptional stage of a gene switches from an active to inactive
state, replication timing shifts from early- to late replicating.
Importantly, it has recently been demonstrated that histone
modifications at an origin of replication serve as a binary switch
Figure 5. INK4a/ARF timing of replication. PCR based analysis of replication timing of the INK4a/ARF locus (exon 1b). BrdU pulse labeled cells
were stained for DNA content with propidium iodide and sorted by flow cytometry into 5 cell cycle fractions (G1, S1, S2, S3 and G2M) according to
DNA content. The Gbe D. melanogaster gene provides a control for recovery of BrdU-labeled DNA.
doi:10.1371/journal.pone.0005622.g005
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human [48]. This replication switch is also observed in human
diseases such as the fragile X syndrome. FMR1 silencing by the
CGG expansion was shown to be mainly attributed to epigenetic
regulated transcriptional silencing [49]. The Fmr1 gene normally
transcribed is replicated early whereas it becomes silent and late
replicating in patients [50,51]. In yeast it was recently shown that
Swi6, an S. pombe counterpart of heterochromatin protein 1 (HP1),
is required for early replication of the pericentromeric region and
the mat locus [52]. In our study we show that in proliferating MEFs
the INK4a/ARF locus is silent and late replicating whereas in
Polycomb mutant the locus tends to be early replicating and
expressed. It has recently been demonstrated in the Encode project
that the H3K27me3 mark shows a positive correlation with late
replication of large DNA segments [53]. We have demonstrated in
senescent and Polycomb mutant cells that the ‘‘bivalent’’ domain at
the INK4a/ARF locus (H3K27me3 and H3K4me3) is resolved and
the locus remains only enriched in H3K4me3 positive marks
correlating with the recruitment of MLL1 protein. Jmjd3 overex-
pression in senescent cells could indicate that this histone
demethylase participates in removing the H3K27 marks at the
INK4A/ARF locus. The epigenetic modifications could be respon-
sible for the observed replication-timing shift at senescence (Fig. 6).
Together, our results demonstrate that MLL1 and Polycomb group
genes directly control the INK4a/ARF locus through chromatin
epigeneticmodifications and that the loss ofthe repressive epigenetic
marks both in senescent and Polycomb mutant cells at an origin of
replication leads to a shift of the replication timing of the locus.
Figure 6. Model for Pc-G and MLL1 proteins in regulation of cellular senescence at the INK4a/ARF locus. (A) In young proliferating cells,
the PRC2 complex is bound at RD and at the INK4a/ARF locus and maintains the levels of H3K27me3. This allows the association of M33 and BMI1-
containing PRC1 complex and repression of the INK4a/ARF genes. (B) In senescent or Polycomb mutant cells binding of EZH2 is lost, leading to the
disruption of the PRC2 complex, the loss of H3K27me3 and to the recruitment of the MLL1 protein. We propose a model in which Polycomb/MLL1
and JMJD3 epigenetic modifications at the RD element impact the replication timing and the expression of the locus. Moreover, in senescent cells
BMI1 binding is specifically lost at the RD element.
doi:10.1371/journal.pone.0005622.g006
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